Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Atherothrombosis

Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

Science in Atherothrombosis

Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Atherothrombosis

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Adherence and persistence analysis in patients treated with DAPT

Atherothrombosis

Adherence and persistence analysis in patients treated with DAPT

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Atherothrombosis

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Atherothrombosis

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Atherothrombosis

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

DAPT in Elderly with CAD Meta Analysis

DAPT in Elderly with CAD Meta Analysis

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources